biote Corp.
BTMD Healthcare Medical Care Facilities
biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024. In the quarter to June 2026, revenue fell 9.48%, EPS fell 330.0%, free cash flow fell 174.2% and total debt rose 16.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow BTMD
biote Corp. (BTMD) Altman Z-score
biote Corp.'s Altman Z-score for fiscal 2025 is 2.65, in the grey zone (1.81–2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 2.65 | 0.60 |
| FY2024 | 2.05 | (0.66) |
| FY2023 | 2.71 | 2.59 |
| FY2022 | 0.12 | (6.20) |
| FY2021 | 6.32 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.09 | — | 0.11 | |
| Retained earnings / total assets | (0.46) | — | −0.64 | |
| EBIT / total assets | 0.33 | — | 1.09 | |
| Market value of equity / total liabilities | 0.51 | — | 0.31 | |
| Sales / total assets | 1.79 | — | 1.79 | |
| Altman Z-score | Grey zone | 2.65 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | 0.97 | ||
Z and Z″ put biote Corp. in different zones: grey zone by Z, distress zone by Z″.
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| BTMD biote Corp. | 2.6× |
| JYNT The Joint Corp. compare | 2.4× |
| AIRS AirSculpt Technologies, Inc. compare | 0.9× |
| CCEL Cryo-Cell International Inc. compare | −0.2× |
| CCM Concord Medical Services Holdings Limited compare | −1.2× |
| PIII P3 Health Partners Inc. compare | −1.3× |
| DCGO DocGo Inc. compare | −1.4× |
| PARK Park Dental Partners, Inc. compare | — |
| PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets